Page last updated: 2024-08-21

pyrazines and Bacterial Infections

pyrazines has been researched along with Bacterial Infections in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abu-Odeh, R; Al-Qawasmeh, RA; Al-Tel, TH; Chouaib, S; El-Awady, R; Saber-Ayad, M; Semreen, MH; Voelter, W	1
Morrison, VA	1
Bostrom, BC; Eckroth, E; Gaynon, PS; Malvar, J; Messinger, YH; Sposto, R; van der Giessen, J	1

Reviews

1 review(s) available for pyrazines and Bacterial Infections

Article	Year
Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Nov-15, Volume: 59 Suppl 5 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Bacterial Infections; Boronic Acids; Bortezomib; Female; Humans; Immune Tolerance; Male; Middle Aged; Mycoses; Neoplasms; Opportunistic Infections; Pyrazines; Tumor Necrosis Factor-alpha; Virus Diseases	2014

Article

Year

Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Nov-15, Volume: 59 Suppl 5

Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Bacterial Infections; Boronic Acids; Bortezomib; Female; Humans; Immune Tolerance; Male; Middle Aged; Mycoses; Neoplasms; Opportunistic Infections; Pyrazines; Tumor Necrosis Factor-alpha; Virus Diseases

2014

Trials

1 trial(s) available for pyrazines and Bacterial Infections

Article	Year
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. Blood, 2012, Jul-12, Volume: 120, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Boronic Acids; Bortezomib; Child; Child, Preschool; Dexamethasone; Doxorubicin; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Opportunistic Infections; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazines; Recurrence; Remission Induction; Treatment Outcome; Vincristine; Young Adult	2012

Article

Year

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.

Blood, 2012, Jul-12, Volume: 120, Issue:2

Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Boronic Acids; Bortezomib; Child; Child, Preschool; Dexamethasone; Doxorubicin; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Opportunistic Infections; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazines; Recurrence; Remission Induction; Treatment Outcome; Vincristine; Young Adult

2012

Other Studies

1 other study(ies) available for pyrazines and Bacterial Infections

Article	Year
Tandem multicomponent reactions toward the design and synthesis of novel antibacterial and cytotoxic motifs. Current medicinal chemistry, 2013, Volume: 20, Issue:11 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Imidazoles; Melanoma; Pyrazines; Pyridines	2013